Background High Na+ intake is a reality in nowadays and is frequently accompanied by renal and cardiovascular alterations. In this study, renal mechanisms underlying perinatal Na+ overload-programmed alterations in Na+ transporters and the renin/angiotensin system (RAS) were investigated, together with effects of short-term treatment with enalapril in terms of reprogramming molecular alterations in kidney. Methodology/Principal Findings Male adult Wistar rats were obtained from dams maintained throughout pregnancy and lactation on a standard diet and drinking water (control) or 0.17 M NaCl (saline group). Enalapril (100 mg/l), an angiotensin converting enzyme inhibitor, was administered for three weeks after weaning. Ninety day old offspring from dams that drank saline presented with proximal tubules exhibiting increased (Na++K+)ATPase expression and activity. Ouabain-insensitive Na+-ATPase activity remained unchanged but its response to angiotensin II (Ang II) was lost. PKC, PKA, renal thiobarbituric acid reactive substances (TBARS), macrophage infiltration and collagen deposition markedly increased, and AT2 receptor expression decreased while AT1 expression was unaltered. Early treatment with enalapril reduced expression and activity of (Na++K+)ATPase, partially recovered the response of Na+-ATPase to Ang II, and reduced PKC and PKA activities independently of whether offspring were exposed to high perinatal Na+ or not. In addition, treatment with enalapril per se reduced AT2 receptor expression, and increased TBARS, macrophage infiltration and collagen deposition. The perinatally Na+-overloaded offspring presented high numbers of Ang II-positive cortical cells, and significantly lower circulating Ang I, indicating that programming/reprogramming impacted systemic and local RAS. Conclusions/Significance Maternal Na+ overload programmed alterations in renal Na+ transporters and in its regulation, as well as severe structural lesions in adult offspring. Enalapril was beneficial predominantly through its influence on Na+ pumping activities in adult offspring. However, side effects including down-regulation of PKA, PKC and AT2 receptors and increased TBARS could impair renal function in later life.
References
[1]
Marin ECS, Balbi APC, Francescato HDC, Alves da Silva CG, Costa RS, et al. (2008) Renal structure and function evaluation of rats from dams that received increased sodium intake during pregnancy and lactation submitted or not to 5/6 nephrectomy. Renal Fail 30: 547–555.
[2]
Cardoso HD, Cabral EV, Vieira-Filho LD, Vieyra A, Paix？o AD (2009) Fetal development and renal function in adult rats prenatally subjected to sodium overload. Pediatr Nephrol 4: 1959–1965.
[3]
Contreras RJ, Wong DL, Henderson R, Curtis KS, Smith JC (2000) High dietary NaCl early in development enhances mean arterial pressure of adult rats. Physiol Behav 71: 173–181.
[4]
da Silva AA, de Noronha IL, de Oliveira IB, Malheiros DM, Heimann JC (2003) Renin-angiotensin system function and blood pressure in adult rats after perinatal salt overload. Nutr Metab Cardiovasc Dis 13: 133–139.
[5]
Balbi AP, Costa RS, Coimbra TM (2004) Postnatal renal development of rats from mothers that received increased sodium intake. Pediatr Nephrol 19: 1212–1218.
[6]
Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, et al. (2003) Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 285: R117–R124.
[7]
Lara LS, Mc-Cormack M, Semprum-Prieto LC, Shenouda S, Majid DS, et al. (2012) AT1 receptor-mediated augmentation of angiotensinogen, oxidative stress, and inflammation in ANG II-salt hypertension. Am J Physiol Renal Physiol 302: F85–F94.
[8]
Rodríguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ (2004) Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol 286: F606–F616.
[9]
Vehaskari VM (2007) Developmental origins of adult hypertension: new insights into the role of the kidney. Pediatr Nephrol. 22: 490–495.
[10]
Tufro-McReddie A, Romano LM, Harris JM, Ferder L, Gomez RA (1995) Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol Renal Physiol 269: F110–F115.
[11]
Akil I, Inan S, Gurcu B, Nazikoglu A, Ozbilgin K, et al. (2005) Histopathological and ultrastructural effects of Losartan on embryonic rat kidney. Acta Histochem 107: 291–300.
[12]
Friberg P, Sundelin B, Bohman SO, Bobik A, Nilsson H, et al. (1994) Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int 45: 485–492.
[13]
Sánchez SI, Seltzer AM, Fuentes LB, Forneris ML, Ciuffo GM (2008) Inhibition of Angiotensin II receptors during pregnancy induces malformations in developing rat kidney. Eur J Pharmacol 588: 114–123.
Miura K, Sekine T, Iida A, Takahashi K, Igarashi T (2009) Salt-losing nephrogenic diabetes insipidus caused by fetal exposure to angiotensin receptor blocker. Pediatr Nephrol 24: 1235–1248.
[16]
Quan A (2006) Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev 82; 23–28.
[17]
Manning J, Vehaskari VM (2005) Postnatal modulation of prenatally programmed hypertension by dietary Na and ACE inhibition. Am J Physiol Regul Integr Comp Physiol 288: R80–R84.
[18]
Vieira-Filho LD, Lara LS, Silva PA, Santos FT, Luzardo R, et al. (2011) Placental malnutrition changes the regulatory network of renal Na-ATPase in adult rat progeny: Reprogramming by maternal α-tocopherol during lactation. Arch Biochem Biophys 505: 91–97.
[19]
Féraille E, Doucet A (2001) Sodium–potassium–adenosinetriphosphatase dependent sodium transport in the kidney: Hormonal control. Physiol Rev 81: 345–418.
[20]
Rangel LB, Lopes AG, Lara LS, Carvalho TL, Silva IV, et al. (2005) PI-PLCβ is involved in the modulation of the proximal tubule Na+-ATPase by angiotensin II. Regul Pept 127: 177–182.
[21]
Maia JCC, Gomes SL, Juliani MH (1993) Genes of Antigenes of Parasites. In:, Morel CM editor. A Laboratory Manual. Rio de Janeiro: Funda？？o Oswaldo Cruz, 146–157.
[22]
Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA (2005) Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 85: 679–715.
[23]
Matos AC, Ladeia AM (2003) Assessment of cardiovascular risk factors in a rural community in the Brazilian state of Bahia. Arq Bras Cardiol 81: 291–302.
[24]
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–227.
Vieyra A, Nachbin L, de Dios–Abad E, Goldfeld M, Meyer–Fernandes JR, et al. (1986) Comparison between calcium transport and adenosine triphosphatase activity in membrane vesicles derived from rabbit kidney proximal tubules. J Biol Chem 261: 4247–4255.
[27]
Proverbio F, Del CastilloJR (1981) Na+-stimulated ATPase activities in kidney basal–lateral plasma membranes. Biochim Biophys Acta 646: 99–108.
[28]
Whittembury G, Proverbio F (1970) Two modes of Na extrusion in cells from guinea pig kidney cortex slices. Pflugers Arch 316: 1–25.
[29]
Cabral LM, Wengert M, da Ressurrei？？o AA, Feres–Elias PH, Almeida FG, et al. (2007) Ceramide is a potent activator of plasma Ca2+-ATPase from kidney proximal tubule cells with protein kinase A as an intermediate. J Biol Chem 282: 24599–24606.
[30]
Axelband F, Assun？？o-Miranda I, de Paula IR, Ferr？o FM, Dias J, et al. (2009) Ang-(3–4) suppresses inhibition of renal plasma membrane calcium pump by Ang II. Regul Pept 155: 81–90.
Tonkiss J, Trzcińska M, Galler JR, Ruiz-Opazo N, Herrera VL (1998) Prenatal malnutrition-induced changes in blood pressure: dissociation of stress and nonstress responses using radiotelemetry. Hypertension 32: 108–114.
[33]
Banday AA, Fazili FR, Lokhandwala MF (2007) Oxidative stress causes renal dopamine D1 receptor dysfunction and hypertension via mechanisms that involve nuclear factor-kappaB and protein kinase C. J Am Soc Nephrol. 18: 1446–1457.
[34]
Boesch DM, Garvin JL (2001) Age-dependent activation of PKC isoforms by angiotensin II in the proximal nephron. Am J Physiol Regul Integr Comp Physiol 281: R861–R867.
[35]
Yang LE, Sandberg MB, Can AD, Pihakaski-Maunsbach K, McDonough AA (2008) Effects of dietary salt on renal Na+ transporter subcellular distribution, abundance, and phosphorylation status. Am J Physiol Renal Physiol 295: F1003–F1016.
[36]
Féraille E, Béguin P, Carranza ML, Gonin S, Rousselot M, et al. (2000) Is phosphorylation of the alpha1 subunit at Ser-16 involved in the control of Na, K-ATPase activity by phorbol ester-activated protein kinase C? Mol Biol Cell 11: 39–50.
[37]
Bertorello A, Aperia A (1988) Pertussis toxin modulates dopamine inhibition of Na, K-ATPase activity in rat proximal convoluted tubule segments. Prog Clin Biol Res 268B: 353–356.
[38]
Zhang L, Zhang Z, Guo H, Wang Y (2008) Na+/K+-ATPase-mediated signal transduction and Na+/K+-ATPase regulation. Fundam Clin Pharmacol 22: 615–621.
[39]
Carranza ML, Rousselot M, Chibalin AV, Bertorello AM, Favre H, et al. (1998) Protein kinase A induces recruitment of active Na+, K+-ATPase units to the plasma membrane of rat proximal convoluted tubule cells. J Physiol (London) 511: 235–243.
[40]
Thomson SC, Deng A, Wead L, Richter K, Blantz RC, et al. (2006) An unexpected role for angiotensin II in the link between dietary salt and proximal reabsorption. J Clin Invest 116: 1110–1116.
[41]
Rocafull MA, Romero FJ, Thomas LE, del CastilloJR (2011) Isolation and cloning of the K+-independent, ouabain-insensitive Na+-ATPase Biochim Biophys Acta. 1808: 1684–1700.
[42]
Be？towski J, Borkowska E, Wójcicka G, Marciniak A (2007) Regulation of renal ouabain-resistant Na+-ATPase by leptin, nitric oxide, reactive oxygen species, and cyclic nucleotides: implications for obesity-associated hypertension. Clin Exp Hypertens 29: 189–207.
[43]
Lara LS, Vives D, Correa JS, Cardozo FP, Marques-Fernades MF, et al. (2010) PKA-mediated effect of MAS receptor in counteracting angiotensin II-stimulated renal Na+-ATPase. Arch Biochem Biophys 496: 117–122.
[44]
Caruso-Neves C, Rangel LB, Vives D, Vieyra A, Coka-Guevara S, et al. (2000) Ouabain-insensitive Na+-ATPase activity is an effector protein for cAMP regulation in basolateral membranes of the proximal tubule. Biochim Biophys Acta 1468: 107–114.
[45]
Li XC, Zhuo JL (2011) Phosphoproteomic analysis of AT1 receptor-mediated signaling responses in proximal tubules of angiotensin II-induced hypertensive rats. Kidney Int 80: 620–632.
[46]
Queiroz-Madeira EP, Lara LS, Wengert M, Landgraf SS, Líbano-Soares JD, et al. (2010) Na(+)-ATPase in spontaneous hypertensive rats: possible AT(1) receptor target in the development of hypertension. Biochim Biophys Acta 1798(3): 360–366.
[47]
Naito T, Ma LJ, Yang H, Zuo Y, Tang Y, et al. (2010) Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis. Am J Physiol Renal Physiol 298: F683–F691.
[48]
Finch JL, Suarez EB, Husain K, Ferder L, Cardema MC, et al. (2012) Effect of combining an ACE inhibitor and a VDR activator on glomerulosclerosis, proteinuria, and renal oxidative stress in uremis rats. Am J Physiol Renal Physiol 302: F141–F149.
[49]
Manning RD Jr, Tian N, Meng S (2005) Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol 25: 311–317.
[50]
Tian N, Moore RS, Braddy S, Rose RA, Gu JW, et al. (2007) Interactions between oxidative stress and inflammation in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol 293: H3388–H3395.
[51]
Wang Z, Tang L, Zhu Q, Yi F, Zhang F, et al. (2011) Hypoxia-inducible factor-1α contributes to the profibrotic action of angiotensin II medullary interstitial cells. Kidney Int 79: 300–310.
[52]
Kobori H, Nangaku M, Navar LG, Nishiyama A (2007) The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59: 251–287.
[53]
Wang CT, Navar LG, Mitchell KD (2003) Proximal tubular fluid angiotensin II levels in angiotensin II-induced hypertensive rats. J Hypertens 21: 353–360.
